Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baimao decoction is a Traditional Chinese Medicine (TCM) herbal formula developed and utilized by the Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine specifically for the treatment of hyperuricemia and gout. The formulation typically centers on *Imperata cylindrica* (Rhizoma Imperatae), often combined with other herbs such as *Smilax glabra* and *Dioscorea septemloba*. It exerts its therapeutic effects through a dual mechanism: inhibiting the enzyme xanthine oxidase to reduce the endogenous production of uric acid, and modulating renal urate transporters to enhance uric acid excretion. In TCM theory, it is used to clear heat, promote diuresis, and resolve dampness, addressing the underlying metabolic imbalances associated with high uric acid levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on baimao decoction.